文献速递眼底病与葡萄膜炎

对非侵入性治疗难治的血管增生性视网膜肿瘤的手术治疗效果

SURGICAL OUTCOMES OF VASOPROLIFERATIVE RETINAL TUMORS' REFRACTORY TO NONINVASIVE THERAPIES.
PubMed 文献 · Retina · 2022-01-01

回顾2005至2020年接受手术治疗的血管增生性视网膜肿瘤(VPT)患者病历,25眼中17眼(68%)因肿瘤活动及相关并发症(视网膜前膜10眼、视网膜脱离8眼、玻璃体出血3眼)接受玻璃体切除术联合眼内激光/冷冻治疗,3例需肿瘤切除;末次随访平均55.4个月时无眼出现肿瘤活动或视网膜脱离,无视网膜前膜复发,平均最佳矫正视力从基线1.2±0.7 logMAR改善至0.7±0.6 logMAR(P<0.05)。

要点

  • 25眼中17眼(68%)因肿瘤活动及并发症接受手术,包括视网膜前膜10眼、视网膜脱离8眼、玻璃体出血3眼。
  • 所有术眼均行玻璃体切除术联合眼内激光/冷冻,3例需肿瘤切除。
  • 末次随访平均55.4个月,无眼出现肿瘤活动或视网膜脱离,无视网膜前膜复发,视力从1.2±0.7改善至0.7±0.6 logMAR(P<0.05)。

核心结论

  • 在这组大型活动性VPT患者中,手术干预使所有患者的肿瘤活动得到控制,并获得总体满意的解剖和功能结局。

研究设计与样本

  • 回顾性分析2005至2020年所有诊断为VPT并接受手术治疗患者的临床病历,评估临床特征、手术技术和结局。

主要发现

  • 25眼(23例患者)中17眼(68%)接受手术以治疗肿瘤活动及相关并发症,包括视网膜前膜10眼(59%)、视网膜脱离8眼(47%)、玻璃体出血3眼(18%)。
  • 所有术眼均行玻璃体切除术联合眼内激光/冷冻以控制肿瘤活动并治疗相关并发症,3例需肿瘤切除。
  • 末次随访(平均55.4个月,范围2-305个月)时,经一次或两次手术后无眼出现肿瘤活动或视网膜脱离,无视网膜前膜复发。
  • 平均基线最佳矫正视力为1.2±0.7 logMAR,平均最终最佳矫正视力为0.7±0.6 logMAR(P<0.05)。
  • 末次随访时12眼(70.5%)最佳矫正视力提高两行或以上。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To evaluate the outcomes of surgical treatment of refractory vasoproliferative retinal tumors (VPTs) and its complications. METHODS: Clinical charts of all patients diagnosed with VPTs who underwent surgical treatment from 2005 to 2020 were reviewed. Clinical features, surgical techniques, and outcomes were evaluated. RESULTS: From 25 eyes of 23 patients with VPTs, 17 (68%) eyes underwent surgical intervention to treat tumor activity and associated complications including epiretinal membrane (n = 10, 59%), retinal detachment (n = 8, 47%), and vitreous hemorrhage (n = 3, 18%). All eyes underwent pars plana vitrectomy with endolaser/cryotherapy to control tumor activity and to treat associated complications. Three cases required tumor resection. At the end of follow-up (mean 55.4 months, range 2-305 months), no eye presented tumor activity or retinal detachment after one or two surgeries. There was no epiretinal membrane recurrence. The mean baseline best-corrected visual acuity was 1.2 ± 0.7 logMAR, and the mean final best-corrected visual acuity was 0.7 ± 0.6 logMAR ( P < 0.05). The best-corrected visual acuity improved two or more lines in 12 (70.5%) eyes at the end of follow-up. CONCLUSION: In this series of patients with large active VPTs, surgical intervention allowed control of the tumor activity in all patients and provided overall satisfactory anatomic and functional outcomes.

来源:Retina,查看原文。版权归原作者所有。

引用

  1. Mares V, Veloso CE, Pulido JS, et al. SURGICAL OUTCOMES OF VASOPROLIFERATIVE RETINAL TUMORS' REFRACTORY TO NONINVASIVE THERAPIES. Retina. 2022. PMID: 35994586. doi:10.1097/IAE.0000000000003520

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。